Puma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, announced the release of four abstracts on its drug candidate ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Hot Corp. News Hot FDA News Trader Talk

Puma Biotechnology (PBYI) Sell-Off on ASCO Abstract 'May be Overdone', Stifel SaysMay 14, 2015 6:26 AM Puma Biotechnology Announces Publication of Abstracts for the 2015 American Society of Clinical Oncology (ASCO) Annual MeetingMay 13, 2015 5:09 PM